News
A Checklist to Help Prevent and Manage Pressure Injury
January 27, 2020
Featured Experts: William Padula, PhD
Research
All Research Featured Research
Evidence Base
Obesity, Second to Smoking as the Most Preventable Cause of US Deaths, Needs New Approaches
January 27, 2020
Featured Experts: Dana Goldman, PhD
Journal Article
Conflicts of Interest in Dialysis: A Barrier to Policy Reforms
January 7, 2020
Featured Experts: Eugene Lin, MD, MS
Journal Article
Outcome Measures for Oncology Alternative Payment Models: Practical Considerations and Recommendations
December 13, 2019
Featured Experts: Jakub Hlávka, PhD
Journal Article
Association Between Spending and Outcomes for Patients With Cancer
December 6, 2019
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
Economic Value of Anti–Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States
November 14, 2019
Featured Experts: Karen Mulligan, PhD, Seth Seabury, PhD, Dana Goldman, PhD
News
Treatments for the Leading Cause of Blindness in the US Generate $0.9 to $3 Billion for Society, According to New Economic Analysis
November 14, 2019
Featured Experts: Karen Mulligan, PhD, Seth Seabury, PhD, Dana Goldman, PhD
Journal Article
The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey
November 13, 2019
Featured Experts: Jakub Hlávka, PhD
Journal Article
The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey
November 2, 2019
Featured Experts: John Romley, PhD, Dana Goldman, PhD
Journal Article
Extended-Release Formulation and Medication Adherence
October 28, 2019
Featured Experts: John Romley, PhD, Dana Goldman, PhD
Evidence Base
Are We Ready to Treat Alzheimer’s?
October 25, 2019
Featured Experts: Jakub Hlávka, PhD
Issue Brief
Future Health Dividends for California: Valuing Medical Innovations
October 15, 2019
Featured Experts: Bryan Tysinger, PhD, Karen Mulligan, PhD, Dana Goldman, PhD
Perspective
Accounting for Hope: Using ‘Mean Survival Gain’ to Price New Cancer Drugs
October 14, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Evidence Base
Who Would Have Believed it? Markets Can Reduce the ‘True’ Price of Cancer Drugs
September 28, 2019
Featured Experts: Dana Goldman, PhD
Journal Article
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017
September 23, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Journal Article
Measuring Alzheimer’s Disease and Other Dementias in Diverse Populations Using Medicare Claims Data
September 12, 2019
Featured Experts: Johanna Thunell, PhD, Julie Zissimopoulos, PhD
Journal Article
Contribution Of Care Source To Cancer Treatment Cost Variation In The US Military Health System
August 13, 2019
Featured Experts: Seth Seabury, PhD